Ron Sugar

Track

Insider profile

Currently holds positions in Uber Technologies Inc, Amgen Inc, Apple Inc and Chevron Corp

Positions

Position Company Period
Independent Chairperson of the Board Uber Technologies Inc July 1, 2018 -
Independent Director Amgen Inc July 22, 2010 -
Independent Director Apple Inc Nov. 17, 2010 -
Lead Independent Director Chevron Corp Jan. 1, 2015 -
Independent Director Air Lease Corp April 1, 2010 - May 1, 2020
Independent Director Chevron Corp April 27, 2005 - Jan. 1, 2015
Ron Sugar's trades of Amgen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
93.27
Quantity 29,141 +4.3%
Value US$4,281,482
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
58.68
Quantity 48,122 -2.3%
Value US$1,082,053
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
402.99
Quantity 62,928 +1.9%
Value US$4,681,426
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
238.40
Quantity 1,000 -6.0%
Value US$238,400
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
235.99
Quantity 1,000 -6.0%
Value US$235,990
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
241.02
Quantity 1,000 -6.0%
Value US$241,020
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
259.79
Quantity 1,000 -6.0%
Value US$259,790
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
228.54
Quantity 1,000 -6.0%
Value US$228,540
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
229.27
Quantity 1,000 -6.1%
Value US$229,270
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
233.35
Quantity 1,000 -6.4%
Value US$233,350
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
215.45
Quantity 2,000 -12.2%
Value US$430,900
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
193.58
Quantity 2,000 -12.2%
Value US$387,160
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
206.70
Quantity 2,000 -12.2%
Value US$413,400
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
183.04
Quantity 2,000 -12.2%
Value US$366,080
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
187.58
Quantity 2,000 -12.2%
Value US$375,160
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
175.68
Quantity 2,000 -12.3%
Value US$351,360
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
175.73
Quantity 2,000 -13.3%
Value US$351,460
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
193.18
Quantity 2,000 -13.3%
Value US$386,360
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
188.88
Quantity 2,000 -13.3%
Value US$377,760
US Amgen Inc (AMGN)
Transaction date
Planned sale
Price
190.00
Quantity 2,000 -13.3%
Value US$380,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-12 2021-05-12
US Amgen Inc (AMGN)
PlS Planned sale
29,141 +4.3%
93.27
US$4,281,482 		29,141 +4.3% 93.27 US$4,281,482
2021-04-15 2021-04-14
US Amgen Inc (AMGN)
PlS Planned sale
48,122 -2.3%
58.68
US$1,082,053 		48,122 -2.3% 58.68 US$1,082,053
2021-03-10 2021-03-10
US Amgen Inc (AMGN)
PlS Planned sale
62,928 +1.9%
402.99
US$4,681,426 		62,928 +1.9% 402.99 US$4,681,426
2021-02-10 2021-02-10
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.0%
238.40
US$238,400 		1,000 -6.0% 238.40 US$238,400
2021-01-14 2021-01-13
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.0%
235.99
US$235,990 		1,000 -6.0% 235.99 US$235,990
2020-08-19 2020-08-19
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.0%
241.02
US$241,020 		1,000 -6.0% 241.02 US$241,020
2020-07-22 2020-07-22
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.0%
259.79
US$259,790 		1,000 -6.0% 259.79 US$259,790
2020-06-17 2020-06-17
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.0%
228.54
US$228,540 		1,000 -6.0% 228.54 US$228,540
2020-05-20 2020-05-20
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.1%
229.27
US$229,270 		1,000 -6.1% 229.27 US$229,270
2020-04-22 2020-04-22
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.4%
233.35
US$233,350 		1,000 -6.4% 233.35 US$233,350
2019-11-07 2019-11-06
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.2%
215.45
US$430,900 		2,000 -12.2% 215.45 US$430,900
2019-10-03 2019-10-02
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.2%
193.58
US$387,160 		2,000 -12.2% 193.58 US$387,160
2019-09-04 2019-09-04
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.2%
206.70
US$413,400 		2,000 -12.2% 206.70 US$413,400
2019-08-08 2019-08-07
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.2%
183.04
US$366,080 		2,000 -12.2% 183.04 US$366,080
2019-07-08 2019-07-03
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.2%
187.58
US$375,160 		2,000 -12.2% 187.58 US$375,160
2019-06-05 2019-06-05
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.3%
175.68
US$351,360 		2,000 -12.3% 175.68 US$351,360
2019-05-03 2019-05-01
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -13.3%
175.73
US$351,460 		2,000 -13.3% 175.73 US$351,460
2019-04-03 2019-04-03
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -13.3%
193.18
US$386,360 		2,000 -13.3% 193.18 US$386,360
2019-03-08 2019-03-06
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -13.3%
188.88
US$377,760 		2,000 -13.3% 188.88 US$377,760
2019-02-11 2019-02-07
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -13.3%
190.00
US$380,000 		2,000 -13.3% 190.00 US$380,000